CORONA REMEDIES
Back to Balance Sheet
|
CORONA REMEDIES Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | |
|---|---|---|---|---|
| Total Current Liabilities | ₹455 Cr | ₹327 Cr | ₹269 Cr | ₹209 Cr |
What is the latest Total Current Liabilities ratio of CORONA REMEDIES ?
| Year | Total Current Liabilities |
|---|---|
| Mar2026 | ₹455 Cr |
| Mar2025 | ₹327 Cr |
| Mar2024 | ₹269 Cr |
| Mar2023 | ₹209 Cr |
How is Total Current Liabilities of CORONA REMEDIES Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹455 Cr | 38.96 | |
| Mar2025 | ₹327 Cr | 21.68 | |
| Mar2024 | ₹269 Cr | 28.46 | |
| Mar2023 | ₹209 Cr | - | |
Compare Total Current Liabilities of peers of CORONA REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CORONA REMEDIES | ₹13,072.3 Cr | 4.4% | 4.4% | NA | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹464,271.0 Cr | -0.5% | -0.3% | 18.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹226,843.0 Cr | 3.1% | 18.9% | 33.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹186,000.0 Cr | -1.5% | -1.6% | 35.6% | Stock Analytics | |
| CIPLA | ₹118,072.0 Cr | -0.9% | 1.6% | -2.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,073.0 Cr | 2% | -3.8% | -0.7% | Stock Analytics | |
CORONA REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CORONA REMEDIES | 4.4% |
4.4% |
|
| SENSEX | -0.8% |
0.5% |
-3.8% |
You may also like the below Video Courses